Medical Device News Magazine

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Henkel, a leading global provider of adhesives, sealants and functional coatings, today announced its membership with MedTech Europe, the industry association representing the medical technology sector in Europe. This collaboration aims to foster innovation and promote sustainable development in the value chains supporting the medical technology industry.

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums. The goal is to accelerate the adoption of innovative solutions, address industry challenges, and contribute to advancing the medical technology sector.

The partnership with MedTech Europe is part of the company’s broader strategy to strengthen its collaborations within the healthcare industry and ecosystem. By collaborating with industry associations, healthcare organizations, and technology providers, Henkel aims to drive innovation and create value for patients, healthcare professionals, and its partners throughout value chains.

“Joining forces with MedTech Europe is an exciting step for us. Together, we will be able to leverage our combined expertise to develop innovative solutions that address the ever-evolving needs of the medical technology industry,” said Dr. Philipp Loosen, Vice President and Head of Industrials EIMEA and Global Key Accounts Medical at Henkel Adhesive Technologies. “MedTech Europe represents the medical technology industry in Europe, covering a wide range of products, including medical devices, diagnostics, imaging equipment, and more.”

Chemical regulatory compliance is important to Henkel, and MedTech Europe provides multiple platforms to collaborate, contribute, and advocate the same through their working groups that deep dive into the aspects of sustainability, chemicals, and medical device regulations. “This is another milestone on our journey to becoming the key player in chemical regulatory compliance for our medical customers that contributes to sustainability and the environment,” said Senthil Pichandi, Vice President Global Product Safety and Regulatory Affairs (PSRA), Henkel Adhesive Technologies.

More here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”